期刊文献+

p53基因 Arg72Pro 多态性与复发性流产相关性的 Meta 分析

Polymorphism of p53 Arg72Pro and recurrent spontaneous abortion:a meta-analysis
下载PDF
导出
摘要 目的:系统地评价 p53基因 Arg72Pro 多态性与复发性流产的相关性。方法计算机检索 PubMed、Chochrane、Medline、CNKI、VIP 和 WanFang Data 数据库,搜集关于 p53基因 Arg72Pro 多态性与复发性流产相关性的研究,检索时限均为从建库至2015年12月3日。由2位研究者独立筛选文献、提取资料和评价纳入研究的偏倚风险后,采用 RevMan 5.3软件进行 Meta 分析。结果最终纳入7个病例对照研究,包括病例组991例,对照组913例。Meta 分析结果显示,p53基因 Arg72Pro 多态性与增加患复发性流产的风险相关(Pro/Pro 与 Arg/Pro +Arg/Arg 的OR =2.22,95% CI 为1.27~3.89;Pro/Pro 与 Arg/Arg 的 OR =2.23,95% CI 为1.05~4.73;Pro/Pro 与 Arg/Pro 的OR =1.89,95% CI 为1.36~2.64)。结论 p53基因 Arg72Pro 多态性与复发性流产发病风险增高相关。 Objective To synthesize evidence on the correlation between p53 Arg72Pro polymorphism and recurrent spontaneous abortion. Methods PubMed,Cochrane,Medline,CNKI,VIP,and WanFang Data were searched from inception to December,2015 to collect studies on the correlation between p53 Arg72Pro polymorphism and recurrent spontaneous abortion.The studies were screened according to the predefined inclusion and exclusion criteria by two researchers independently.The quality of each report was evaluated,the data were extracted,and then meta-analysis was performed using RevMan 5.3 software. Results A total of 7 case-control studies involving 991 cases and 913 controls were identified.The results of meta-analysis showed that p53 Arg72Pro polymorphism was associated with an increased risk of recurrent spontaneous abortion (Pro /Pro vs Arg/Pro +Arg/Arg:OR =2.22,95%CI:1.27 -3.89;Pro /Pro vs Arg/Arg:OR =2.23,95% CI:1.05 -4.73;Pro /Pro vs Arg/Pro:OR =1.89,95% CI:1.36 -2.64 ). Conclusion The p53 Arg72Pro polymorphism is associated with an elevated risk of recurrent spontaneous abortion.
出处 《中国生育健康杂志》 2016年第5期401-407,共7页 Chinese Journal of Reproductive Health
基金 国家自然科学基金项目(81273791)
关键词 P53 基因 复发性流产 META 分析 p53 gene Recurrent Spontaneous Abortion Meta-analysis
  • 相关文献

参考文献25

  • 1Saravelos SH, Cocksedge KA, Li TC. The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage. Reprod Biomed Online,2010,20:416-422.
  • 2Banch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage. N Engl J Med ,2010,363 : 1740-1747.
  • 3叶喜阳,徐宏里,黄文青.反复自然流产患者血清及胎盘绒毛组织中细胞因子的研究.中国妇幼保健,2006,21:2132-2134.
  • 4Li Z,Ni M, Li J, et al. Decision making of the p53 network:Death by integration. J Theor Biol,2011,271:205-211.
  • 5Thomas M, Kalita A, Labrecque S, et al. Two polymorphie variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 1999,19 : 1092-1100.
  • 6Pietrowski D, Bettendorf H, Riener EK, et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumor suppressor gene. Hum Reprod ,2005,20:848-851.
  • 7Kay C, Jeyendran RS, Coulam CB. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online ,2006,13:492-496.
  • 8Firouzabadi RD, Ghasemi N, Rozbahani MA, et al. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss. Aust N Z I Obstet Gynaeco1,2009 ,49 :216-219.
  • 9Kaare M, Butzow R, Ulander VM, et al. Study of p53 gene mutations and placental expression in recurrent miscarriage cases. Reprod Biomed Online,2009,18:430-435.
  • 10Tang W, Zhou X, Chan Y, et al. p53 eodon 72 polymorphism and recurrent pregrlaney loss: a recta-analysis. J Assist Reprod Genet, 2011,28:965-969.

二级参考文献25

  • 1葛京平,魏武,魏威,张征宇,高建平,马驰原.survivin在膀胱癌中的表达及其临床意义[J].医学研究生学报,2006,19(8):716-718. 被引量:9
  • 2Lee EM, Ruth MP, Cristina P, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study : a case-control study [ J]. Lancet Oncol,2008, 9(4) : 359-366.
  • 3Jorunn L, Vendil V, Jens GH, et al. Immunohistoehemical markers in urinary bladder carcinomas from paraf? n-embedded archival tissue after storage for 5-70 years[ J]. BJU Int,2007,99 (5) :1013-1019.
  • 4Gregor M. Clinical Pathology of Urologic Tumors [ M]. London: Informa ,2007:57-58.
  • 5Antonio SS, Juan GL, Jose MG, et ol. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: A long-term study[J]. Urol Oncol,2008,26(6) : 620-626.
  • 6Fu TY, Tu MS, Tseng HH, et al. Overexpression of p27kipl in urinary bladder urothelial carcinoma [ J]. Int J Urol, 2007 , 14 (12) :1084-1087.
  • 7Ye Y, Yang H, Grossman HB, et al. Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Bladder Cancer [ J]. Cancer , 2008 ,112 ( 11 ) :2467-2474.
  • 8Kesavan E, Edmund C, Thomas PT, et al. Predictive Value of p53 and pRb Expression in Superficial Bladder Cancer Patients Treated With BCG and Interferon-alpha[ J]. Cancer, 2007 ,109 (6) :1097-1105.
  • 9Lopez-Behran A, Requena A J, Luque R J, et al. Cyclin D3 expression in primary Ta/T1 bladder cancer[ J]. J Pathol,2006, 209(1) : 106-113.
  • 10Shahrokh FS, Raheela A, Arthur IS, et al. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder [J]. Urol Oncol,2007,25(6) :468-475.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部